Teladoc Health (NYSE:TDOC) PT Lowered to $20.00
Teladoc Health (NYSE:TDOC – Free Report) had its target price cut by Barclays from $25.00 to $20.00 in a report released on Friday, Benzinga reports. They currently have an overweight rating on the health services provider’s stock. A number of other equities analysts also recently commented on the company. Piper Sandler dropped their price objective […]